Imaging the intracellular distribution of tyrosine kinase inhibitors in living cells with quantitative hyperspectral stimulated Raman scattering

Nature Chemistry

Volumn 6, Issue 7, 2014, Pages 614-622

  Fu, Dan ^a   Zhou, Jing ^b   Zhu, Wenjing Suzanne ^b   Manley, Paul W ^c   Wang, Y Karen ^b   Hood, Tami ^b   Wylie, Andrew ^b   Xie, X Sunney ^a  

^a HARVARD UNIVERSITY   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE INHIBITOR;

ARTICLE; CELL TRACKING; CONFOCAL MICROSCOPY; CYTOLOGY; EUKARYOTIC CELL; HUMAN; METABOLISM; METHODOLOGY; RAMAN SPECTROMETRY;

CELL TRACKING; EUKARYOTIC CELLS; HUMANS; MICROSCOPY, CONFOCAL; PROTEIN KINASE INHIBITORS; SPECTRUM ANALYSIS, RAMAN;

EID: 84903185441     PISSN: 17554330     EISSN: 17554349     Source Type: Journal    
DOI: 10.1038/nchem.1961     Document Type: Article

References (38)

1. Melo, J. V. & Barnes, D. J. Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nature Rev. Cancer 7, 441-453 (2007).
2. Manley, P. W. et al. Structural resemblances and comparisons of the relative pharmacological properties of imatinib and nilotinib. Biorg. Med. Chem. 18, 6977-6986 (2010).
3. Adrian, F. J. et al. Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nature Chem. Biol. 2, 95-102 (2006).
4. Bellodi, C. et al. Targeting autophagy potentiates tyrosine kinase inhibitorinduced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J. Clin. Invest. 119, 1109-1123 (2009).
5. Gupta, A. et al. Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST). Proc. Natl Acad. Sci. 107, 14333-14338 (2010).
6. Lee, C. M. & Tannock, I. F. Inhibition of endosomal sequestration of basic anticancer drugs: influence on cytotoxicity and tissue penetration. Br. J. Cancer 94, 863-869 (2006).
7. Rubinsztein, D. C., Codogno, P. & Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nature Rev. Drug Discov. 11, 709-730 (2012).
8. Verschooten, L. et al. Autophagy inhibitor chloroquine enhanced the cell death inducing effect of the flavonoid luteolin in metastatic squamous cell carcinoma cells. Plos One 7, e48264 (2012).
9. Lamoureux, F. et al. Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor, AZD5363. Clin. Cancer. Res. 19, 833-844 (2013).
10. Zinn, R. et al. Combination treatment with ABT-737 and chloroquine in preclinical models of small cell lung cancer. Mol. Cancer 12, 16 (2013).
11. Maycotte, P. et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy 8, 200-212 (2012).
12. Satori, C. P. et al. Bioanalysis of eukaryotic organelles. Chem. Rev. 113, 2733-2811 (2013).
13. Baik, J. & Rosania, G. R. Molecular imaging of intracellular drug-membrane aggregate formation. Mol. Pharm. 8, 1742-1749 (2011).
14. Ling, J., Weitman, S. D., Miller, M. A., Moore, R. V. & Bovik, A. C. Direct Raman imaging techniques for study of the subcellular distribution of a drug. Appl. Opt. 41, 6006-6017 (2002).
15. Salehi, H. et al. Label-free detection of anticancer drug paclitaxel in living cells by confocal Raman microscopy. Appl. Phys. Lett. 102, 113701 (2013).
16. Matthäus, C. et al. in Confocal Raman Microscopy (eds Dieing, T., Hollricher, O. & Toporski, J.) Ch. 7, 137-163 (Springer Series in Optical Sciences 158, Springer, 2011).
17. Harada, Y. et al. Intracellular dynamics of topoisomerase I inhibitor, CPT-11, by slit-scanning confocal Raman microscopy. Histochem. Cell Biol. 132, 39-46 (2009).
18. Freudiger, C. W. et al. Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy. Science 322, 1857-1861 (2008).
19. Wang, M. C., Min, W., Freudiger, C. W., Ruvkun, G. & Xie, X. S. RNAi screening for fat regulatory genes with SRS microscopy. Nature Methods 8, 135-138 (2011).
20. Freudiger, C. W. et al. Multicolored stain-free histopathology with coherent Raman imaging. Lab. Invest. 92, 1492-1502 (2012).
21. Zhang, X. et al. Label-free live-cell imaging of nucleic acids using stimulated Raman scattering microscopy. Chemphyschem 13, 1054-1059 (2012).
22. Fu, D. et al. Quantitative chemical imaging with multiplex stimulated Raman scattering microscopy. J. Am. Chem. Soc. 134, 3623-3626 (2012).
23. Ozeki, Y. et al. High-speed molecular spectral imaging of tissue with stimulated Raman scattering. Nature Photon. 6, 845-851 (2012).
24. Fu, D., Holtom, G., Freudiger, C., Zhang, X. & Xie, X. S. Hyperspectral imaging with stimulated Raman scattering by chirped femtosecond lasers. J. Phys. Chem. B 117, 4634-4640 (2013).
25. Zhang, D. et al. Quantitative vibrational imaging by hyperspectral stimulated Raman scattering microscopy and multivariate curve resolution analysis. Anal. Chem. 85, 98-106 (2013).
26. Colthup, N. B., Daly, L. H. & Wiberley, S. E. Introduction to Infrared and Raman Spectroscopy (Academic Press, 1990).
27. Cǐntǎ-Pǐnzaru, S. et al. FT-Raman and NIR-SERS characterization of the antimalarial drugs chloroquine and mefloquine and their interaction with hematin. J. Raman Spectrosc. 37, 326-334 (2006).
28. De Duve, C. et al. Lysosomotropic agents. Biochem. Pharmacol. 23, 2495-2531 (1974).
29. Trapp, S., Rosania, G. R., Horobin, R. W. & Kornhuber, J. Quantitative modeling of selective lysosomal targeting for drug design. Eur. Biophys. J. 37, 1317-1328 (2008).
30. Codogno, P. & Meijer, A. J. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 12, 1509-1518 (2005).
31. Kimura, T., Takabatake, Y., Takahashi, A. & Isaka, Y. Chloroquine in cancer therapy: a double-edged sword of autophagy. Cancer Res. 73, 3-7 (2013).
32. Poole, B. & Ohkuma, S. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages. J. Cell Biol. 90, 665-669 (1981).
33. Zheng, N., Zhang, X. & Rosania, G. R. Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. J. Pharmacol. Exp. Ther. 336, 661-671 (2011).
34. Larson, R. A. et al. Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study. Blood 111, 4022-4028 (2008).
35. Deininger, M. W. Nilotinib. Clin. Cancer. Res. 14, 4027-4031 (2008).
36. Yamakoshi, H. et al. Alkyne-tag Raman imaging for visualization of mobile small molecules in live cells. J. Am. Chem. Soc. 134, 20681-20689 (2012).
37. Palacios, R. & Steinmetz, M. IL3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734 (1985).
38. Daley, G. Q. & Baltimore, D. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein. Proc. Natl Acad. Sci. 85, 9312-9316 (1988).